BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10211922)

  • 21. Mania associated with venlafaxine discontinuation.
    Fava GA; Mangelli L
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):89-90. PubMed ID: 12899740
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment: hyponatremia with venlafaxine.
    Boyd IW
    Ann Pharmacother; 1998 Sep; 32(9):981-2. PubMed ID: 9762390
    [No Abstract]   [Full Text] [Related]  

  • 23. Venlafaxine withdrawal in organic anxiety disorder.
    Jhirwal OP; Chakrabarti S
    Indian J Med Sci; 2003 Dec; 57(12):559-60. PubMed ID: 14701949
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    Bertolín-Guillén JM; Climent-Díaz B; Navarré-Gimeno A
    Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
    [No Abstract]   [Full Text] [Related]  

  • 25. Venlafaxine-induced excessive yawning.
    Chen CH; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):156-7. PubMed ID: 19000733
    [No Abstract]   [Full Text] [Related]  

  • 26. Venlafaxine augmentation with lithium leading to serotonin syndrome.
    Shahani L
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E47. PubMed ID: 23037683
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possible serotonin syndrome associated with administration of venlafaxine and tramadol].
    Albiñana Pérez MS; Cea Pereira L; Bilbao Salcedo J; Rodríguez Penín I
    Farm Hosp; 2012; 36(6):548. PubMed ID: 23461451
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced testosterone level in a venlafaxine treated patient.
    Bell S; Shipman M
    Ann Clin Psychiatry; 2000 Sep; 12(3):171-3. PubMed ID: 10984008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release venlafaxine-induced alopecia.
    Pereira CE; Goldman-Levine JD
    Ann Pharmacother; 2007 Jun; 41(6):1084. PubMed ID: 17519298
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
    Denys D; Kavelaars A; Heijnen CJ; Westenberg H
    Psychopharmacology (Berl); 2002 Dec; 164(4):432. PubMed ID: 12457275
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychogenic movement disorder after a venlafaxine-induced dystonia.
    Fonseca L; Rodrigues M; Machado A
    Mov Disord; 2010 Mar; 25(4):506-7. PubMed ID: 20014065
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible venlafaxine withdrawal syndrome.
    Farah A; Lauer TE
    Am J Psychiatry; 1996 Apr; 153(4):576. PubMed ID: 8599410
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine.
    Tham CJ; Trew M; Brager N
    Can J Psychiatry; 1999 Nov; 44(9):923-4. PubMed ID: 10584166
    [No Abstract]   [Full Text] [Related]  

  • 34. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
    Koren G; Moretti M; Kapur B
    J Obstet Gynaecol Can; 2006 Apr; 28(4):299-301. PubMed ID: 16776907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome after venlafaxine.
    Cassidy EM; O'Kearne V
    Lancet; 2000 Jun; 355(9221):2164-5. PubMed ID: 10902652
    [No Abstract]   [Full Text] [Related]  

  • 37. Mania induced by tramadol-venlafaxine combination.
    Hefzi N; Grekin J; Ahmed A
    J Opioid Manag; 2019; 15(4):342-344. PubMed ID: 31637686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flushing in a menopausal woman taking venlafaxine.
    Grady-Weliky TA; Hartmann DM
    Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
    [No Abstract]   [Full Text] [Related]  

  • 39. Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks.
    Kolecki P
    J Toxicol Clin Toxicol; 1997; 35(2):211-2. PubMed ID: 9120894
    [No Abstract]   [Full Text] [Related]  

  • 40. Venlafaxine-induced complex visual hallucinations in a 17-year-old boy.
    Jacob MK; Ash P
    J Clin Psychiatry; 2009 Apr; 70(4):601-3. PubMed ID: 19403099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.